PetMed Express, Inc.
corporate_fare Company Profile
PetMed Express, Inc. (NASDAQ:PETS) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 18 items for PETS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-17, rated 7/10. Across its 18 most recent items scored 7 or higher, the top rating is 9/10, with 14 rated 8 or above. Recent SEC coverage for PETS spans 8-K, 10-Q, SCHEDULE 13D/A, DEF 14A.
Recent high-impact activity:
- PetMeds Names Jeff Willard CEO; Campbell Retires, Mennen Becomes Chair
- PetMed Express Q1 Loss Narrows to $6.1M, But Cash Burn and Going Concern Doubt Persist
- PetMed Q1 Loss Narrows to $6.1M, Sales Stabilize Sequentially
- PetMeds Q1 Sales Fall 20% to $41M, Loss Narrows to $0.28/Share
- PetMed Express Unlocks $37M in Cash Through HQ Sale-Leaseback Amid Going-Concern Fears
Financial Snapshot
Short Interest & Short Volume
6.79 days to coverFINRA reported short interest of 569,173 shares in PETS as of the September 15, 2026 settlement, a 12.1% decrease from the prior period — about 6.8 days to cover at its recent average daily volume. On October 2, 2026, 59.3% of PETS volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.